Detecting Ovarian Cancer Earlier with New MIT Tissue Sampling Device
Sep 24, 2026
Researchers at MIT and Johns Hopkins have developed a 3D printed microfluidic device that gently collects living cells from the surface of tissues using microfluidic…
Read More –Just a Flesh Wound: The Combative Quest for Cancer’s Holy Grail
Sep 25, 2026Off Script: Why Some CAR T Patients Develop Enterocolitis—and How to Treat It
Sep 23, 2026New Immunotherapy Strategy Extends KRAS Inhibitor Response in Pancreatic Cancer
Sep 23, 2026Breast Cancer-Linked Chemicals Widespread in U.S. Consumer Products
Sep 23, 2026Signatera Surges in Liquid Biopsy Race with New Lung Cancer Data and a Japan Approval
Sep 23, 2026Inherited EGFR Mutation Raises Lung Cancer Risk in Nonsmokers
Sep 23, 2026Alzheimer’s Drug Effects Revealed with Plasma Biomarker Changes
Sep 25, 2026
Engineers Use the Body as a Network to Connect Wearable and Implantable Devices
Sep 24, 2026
Gut Microbiome Development Pattern Linked to Type 1 Diabetes Risk
Sep 23, 2026
Oral Drug Shows Promise in Protecting Against Diabetic Eye Disease
Sep 23, 2026
Ultra-Processed Foods Linked with Multiple Health Outcomes
Sep 23, 2026
Cancer Risk Gap Widens for People with Type 2 Diabetes
Sep 22, 2026
Highly Multiplexed Droplet Digital PCR for Ultra-Sensitive NSCLC Biomarker Detection in Research Workflows
In this IPM webinar, two experts will discuss the growing role of ddPCR in clinical research and translational oncology.
Surbhi Jain, PhD, MBBS
Staff Scientist
Bio-Rad Laboratories
Prithwish Pal, PhD
Director, Global Product Marketing – Oncology
Bio-Rad Laboratories
Paper Battery Prototype Could Power Devices Inside the Body for Days
Sep 21, 2026A prototype of an ingestible paper battery that lasts for at least three days and breaks down without notable toxicity was successfully tested in pigs.
Tumors Can Hide p53 Neoantigens from T Cells, Study Finds
Sep 18, 2026A new study shows that tumors can suppress the presentation of potentially actionable p53 neoantigens, highlighting a limitation of sequence-based target prediction and a possible…
AI Agents Collaborate to Streamline Drug Discovery
Sep 17, 2026A research platform that coordinates virtual AI “agents,” each modeled on a different division of a traditional drug-development company, could optimize the selection of candidate…
Podcast Series
Behind the Breakthroughs
Join host Jonathan D. Grinstein, PhD, North American Editor for Inside Precision Medicine, as he uncovers the stories behind the pioneers driving the precision medicine revolution.
Stay up to date with the latest episodes of Behind the Breakthroughs by subscribing to the IPM eNewsletter.


